Janardan Khandekar to Cost-Benefit Analysis
This is a "connection" page, showing publications Janardan Khandekar has written about Cost-Benefit Analysis.
Connection Strength
0.040
-
Recommendations on follow-up of breast cancer patients following primary therapy. Semin Surg Oncol. 1996 Sep-Oct; 12(5):346-51.
Score: 0.027
-
Recurrence in patients on adjuvant chemotherapy for breast cancer. Cancer. 1985 Dec 01; 56(11):2736.
Score: 0.013